New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2012
08:08 EDTCOVCovidien raises FY13 Phamaceutical unit sales growth guidance to up 3%-6%
Covidien announced that as a result of the FDA approval of its generic version of CONCERTA and continued good operational performance, Covidien is increasing the fiscal 2013 net sales guidance for the Pharmaceuticals segment to 3%-6% above 2012 from the previous range of 1%-4% above 2012. There are no other changes to Covidien’s previously announced 2013 guidance, the company said, adding that more details will be provided on January 25, 2013, when the company announces its first-quarter results. Covidien announced in December 2011 that it plans to spin off its Pharmaceuticals segment, Mallinckrodt, into a stand-alone company, a process expected to be completed in mid-2013.
News For COV From The Last 14 Days
Check below for free stories on COV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
07:30 EDTCOVQ1 Productions to hold a conference
Subscribe for More Information
06:52 EDTCOVFormer official says Obama could limit inversion deals, NY Times reports
President Obama could limit tax inversion deals on his own authority, said Stephen Shay, former deputy assistant Treasury secretary for international tax affairs in the Obama administration, according to The New York Times. A 1969 law gives the president the ability to restrict inversion deals, said Shay, who also worked in the Reagan administration, the newspaper stated. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Alletgan (AGN). Reference Link
July 25, 2014
06:30 EDTCOVObama calls on Congress to end inversion deals, NY Times reports
Subscribe for More Information
06:05 EDTCOVCovidien reports Q3 Surgical Solutions sales up 8% to $1.31B
Reports Q3 Vascular Therapies sales flat to $417M; Reports Q3 Respiratory and Patient Care sales up 2% to $966M.
06:03 EDTCOVCovidien reports Q3 adjusted EPS $1.04, consensus $1.00
Subscribe for More Information
July 24, 2014
15:29 EDTCOVNotable companies reporting before tomorrow's open
Subscribe for More Information
14:35 EDTCOVObama to call for elimination of tax inversion deals, NY Times says
President Obama will call on Congress today to eliminate the tax inversion loophole, according to The New York Times. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott’s (ABT), Medtronic's acquisition of Covidien (COV)and Valeant's (VRX) proposed takeover of Alletgan (AGN)Reference Link
July 23, 2014
06:45 EDTCOVLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
July 22, 2014
07:07 EDTCOVCovidien names Bryan Hanson as group president, effective October 1
Subscribe for More Information
July 21, 2014
08:16 EDTCOVDeutsche Bank analysts hold an analyst/industry conference call
Subscribe for More Information
July 18, 2014
12:51 EDTCOVKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
11:34 EDTCOVOptions with increasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use